# Cleveland-Cliffs Inc.: financial statements, quarterly

CLF · NYSE · CIK 764065 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/clf.md) · [Financials](/companies/clf/financials.md) · [Filings](/companies/clf/filings.md) · [Insiders](/companies/clf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/clf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,112 d](/filings/0000764065-26-000025.md) | [5,199](/filings/0000764065-25-000103.md) | [5,092](/filings/0000764065-25-000124.md) | [4,569](/filings/0000764065-25-000149.md) | [4,325 d](/filings/0000764065-26-000025.md) | [4,629](/filings/0000764065-26-000070.md) | [4,934](/filings/0000764065-26-000100.md) | [4,734](/filings/0000764065-26-000115.md) | [4,313 d](/filings/0000764065-26-000025.md) | [4,922](/filings/0000764065-26-000070.md) | [5,226](/filings/0000764065-26-000100.md) | [5,612](/filings/0000764065-26-000115.md) |
| Cost of revenue | $m | [4,962 d](/filings/0000764065-26-000025.md) | [4,914](/filings/0000764065-25-000103.md) | [4,930](/filings/0000764065-25-000124.md) | [4,675](/filings/0000764065-25-000149.md) | [4,598 d](/filings/0000764065-26-000025.md) | [5,025](/filings/0000764065-26-000070.md) | [5,146](/filings/0000764065-26-000100.md) | [4,780](/filings/0000764065-26-000115.md) | [4,519 d](/filings/0000764065-26-000025.md) | [5,004](/filings/0000764065-26-000070.md) | [5,094](/filings/0000764065-26-000100.md) | [5,147](/filings/0000764065-26-000115.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [162 d](/filings/0000764065-26-000025.md) | [132](/filings/0000764065-25-000103.md) | [103](/filings/0000764065-25-000124.md) | [112](/filings/0000764065-25-000149.md) | [139 d](/filings/0000764065-26-000025.md) | [133](/filings/0000764065-26-000070.md) | [137](/filings/0000764065-26-000100.md) | [130](/filings/0000764065-26-000115.md) | [143 d](/filings/0000764065-26-000025.md) | [125](/filings/0000764065-26-000070.md) | [154](/filings/0000764065-26-000100.md) | [153](/filings/0000764065-26-000115.md) |
| Operating income | $m | [(118) d](/filings/0000764065-26-000025.md) | [(38.0)](/filings/0000764065-25-000103.md) | [6.0](/filings/0000764065-25-000124.md) | [(261)](/filings/0000764065-25-000149.md) | [(465) d](/filings/0000764065-26-000025.md) | [(543)](/filings/0000764065-26-000070.md) | [(501)](/filings/0000764065-26-000100.md) | [(204)](/filings/0000764065-26-000115.md) | [(331) d](/filings/0000764065-26-000025.md) | [(213)](/filings/0000764065-26-000070.md) | [(49.0)](/filings/0000764065-26-000100.md) | [311](/filings/0000764065-26-000115.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [26.0 d](/filings/0000764065-26-000025.md) | [(8.0)](/filings/0000764065-25-000103.md) | [(15.0)](/filings/0000764065-25-000124.md) | [(76.0)](/filings/0000764065-25-000149.md) | [(136) d](/filings/0000764065-26-000025.md) | [(149)](/filings/0000764065-26-000070.md) | [(148)](/filings/0000764065-26-000100.md) | [(78.0)](/filings/0000764065-26-000115.md) | [(206) d](/filings/0000764065-26-000025.md) | [(81.0)](/filings/0000764065-26-000070.md) | [(20.0)](/filings/0000764065-26-000100.md) | [46.0](/filings/0000764065-26-000115.md) |
| Net income | $m | [(169) d](/filings/0000764065-26-000025.md) | [(67.0)](/filings/0000764065-24-000108.md) | [2.0](/filings/0000764065-24-000167.md) | [(244)](/filings/0000764065-25-000149.md) | [(447) d](/filings/0000764065-26-000025.md) | [(498)](/filings/0000764065-26-000070.md) | [(486)](/filings/0000764065-26-000100.md) | [(251)](/filings/0000764065-26-000115.md) | [(243) d](/filings/0000764065-26-000025.md) | [(237)](/filings/0000764065-26-000070.md) | [(145)](/filings/0000764065-26-000100.md) | [152](/filings/0000764065-26-000115.md) |
| Diluted EPS | $ per share | not reported | [(0.14)](/filings/0000764065-24-000108.md) | [0.00](/filings/0000764065-24-000167.md) | [(0.52)](/filings/0000764065-25-000149.md) | not reported | [(1.01)](/filings/0000764065-26-000070.md) | [(0.98)](/filings/0000764065-26-000100.md) | [(0.51)](/filings/0000764065-26-000115.md) | not reported | [(0.42)](/filings/0000764065-26-000070.md) | [(0.25)](/filings/0000764065-26-000100.md) | [0.26](/filings/0000764065-26-000115.md) |
| Basic EPS | $ per share | not reported | [(0.14)](/filings/0000764065-24-000108.md) | [0.00](/filings/0000764065-24-000167.md) | [(0.52)](/filings/0000764065-25-000149.md) | not reported | [(1.01)](/filings/0000764065-26-000070.md) | [(0.98)](/filings/0000764065-26-000100.md) | [(0.51)](/filings/0000764065-26-000115.md) | not reported | [(0.42)](/filings/0000764065-26-000070.md) | [(0.25)](/filings/0000764065-26-000100.md) | [0.27](/filings/0000764065-26-000115.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000764065-26-000025.md) | [0.0](/filings/0000764065-25-000103.md) | [0.1](/filings/0000764065-25-000124.md) | [0.0](/filings/0000764065-24-000206.md) | [0.1](/filings/0000764065-26-000025.md) | [0.1](/filings/0000764065-25-000103.md) | [0.1](/filings/0000764065-25-000124.md) | [0.1](/filings/0000764065-25-000149.md) | [0.1](/filings/0000764065-26-000115.md) | [0.0](/filings/0000764065-26-000070.md) | [0.1](/filings/0000764065-26-000100.md) | [0.1](/filings/0000764065-26-000115.md) |
| Current assets | $bn | [6.6](/filings/0000764065-25-000058.md) | [6.5](/filings/0000764065-24-000108.md) | [6.2](/filings/0000764065-24-000167.md) | [6.0](/filings/0000764065-24-000206.md) | [6.9](/filings/0000764065-26-000025.md) | [7.0](/filings/0000764065-25-000103.md) | [6.7](/filings/0000764065-25-000124.md) | [6.7](/filings/0000764065-25-000149.md) | [6.4](/filings/0000764065-26-000115.md) | [6.7](/filings/0000764065-26-000070.md) | [6.8](/filings/0000764065-26-000100.md) | [7.1](/filings/0000764065-26-000115.md) |
| Total assets | $bn | [17.5](/filings/0000764065-26-000025.md) | [17.2](/filings/0000764065-24-000108.md) | [16.9](/filings/0000764065-24-000167.md) | [16.8](/filings/0000764065-24-000206.md) | [20.9](/filings/0000764065-26-000025.md) | [20.8](/filings/0000764065-25-000103.md) | [20.5](/filings/0000764065-25-000124.md) | [20.3](/filings/0000764065-25-000149.md) | [20.0](/filings/0000764065-26-000115.md) | [20.1](/filings/0000764065-26-000070.md) | [20.1](/filings/0000764065-26-000100.md) | [20.3](/filings/0000764065-26-000115.md) |
| Current liabilities | $bn | [3.5](/filings/0000764065-25-000058.md) | [3.4](/filings/0000764065-24-000108.md) | [3.3](/filings/0000764065-24-000167.md) | [3.3](/filings/0000764065-24-000206.md) | [3.4](/filings/0000764065-26-000025.md) | [3.3](/filings/0000764065-25-000103.md) | [3.3](/filings/0000764065-25-000124.md) | [3.3](/filings/0000764065-25-000149.md) | [3.3](/filings/0000764065-26-000115.md) | [3.3](/filings/0000764065-26-000070.md) | [3.6](/filings/0000764065-26-000100.md) | [3.8](/filings/0000764065-26-000115.md) |
| Total liabilities | $bn | [9.4](/filings/0000764065-25-000058.md) | [9.8](/filings/0000764065-24-000108.md) | [9.6](/filings/0000764065-24-000167.md) | [9.7](/filings/0000764065-24-000206.md) | [14.1](/filings/0000764065-26-000025.md) | [14.4](/filings/0000764065-25-000103.md) | [14.4](/filings/0000764065-25-000124.md) | [14.6](/filings/0000764065-25-000149.md) | [13.7](/filings/0000764065-26-000115.md) | [14.1](/filings/0000764065-26-000070.md) | [14.3](/filings/0000764065-26-000100.md) | [14.4](/filings/0000764065-26-000115.md) |
| Long-term debt | $bn | [3.1](/filings/0000764065-25-000058.md) | [3.7](/filings/0000764065-24-000108.md) | [3.5](/filings/0000764065-24-000167.md) | [3.8](/filings/0000764065-24-000206.md) | [7.1](/filings/0000764065-26-000025.md) | [7.6](/filings/0000764065-25-000103.md) | [7.7](/filings/0000764065-25-000124.md) | [8.0](/filings/0000764065-25-000149.md) | [7.3](/filings/0000764065-26-000115.md) | [7.8](/filings/0000764065-26-000070.md) | [7.7](/filings/0000764065-26-000100.md) | [7.6](/filings/0000764065-26-000115.md) |
| Current portion of debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [7.9](/filings/0000764065-25-000058.md) | [7.2](/filings/0000764065-24-000108.md) | [7.1](/filings/0000764065-24-000167.md) | [6.9](/filings/0000764065-24-000206.md) | [6.6](/filings/0000764065-26-000025.md) | [6.3](/filings/0000764065-25-000103.md) | [5.8](/filings/0000764065-25-000124.md) | [5.5](/filings/0000764065-25-000149.md) | [6.1](/filings/0000764065-26-000115.md) | [5.8](/filings/0000764065-26-000070.md) | [5.6](/filings/0000764065-26-000100.md) | [5.7](/filings/0000764065-26-000115.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [652 d](/filings/0000764065-26-000025.md) | [142](/filings/0000764065-25-000103.md) | [519 d](/filings/0000764065-25-000124.md) | [(84.0) d](/filings/0000764065-25-000149.md) | [(472) d](/filings/0000764065-26-000025.md) | [(351)](/filings/0000764065-26-000070.md) | [45.0 d](/filings/0000764065-26-000100.md) | [(143) d](/filings/0000764065-26-000115.md) | [(13.0) d](/filings/0000764065-26-000025.md) | [(325)](/filings/0000764065-26-000070.md) | [230 d](/filings/0000764065-26-000100.md) | [224 d](/filings/0000764065-26-000115.md) |
| Capital expenditure | $m | [165 d](/filings/0000764065-26-000025.md) | [182](/filings/0000764065-25-000103.md) | [157 d](/filings/0000764065-25-000124.md) | [151 d](/filings/0000764065-25-000149.md) | [205 d](/filings/0000764065-26-000025.md) | [152](/filings/0000764065-26-000070.md) | [112 d](/filings/0000764065-26-000100.md) | [157 d](/filings/0000764065-26-000115.md) | [140 d](/filings/0000764065-26-000025.md) | [152](/filings/0000764065-26-000070.md) | [157 d](/filings/0000764065-26-000100.md) | [152 d](/filings/0000764065-26-000115.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000764065-26-000025.md) | [608](/filings/0000764065-25-000103.md) | [125 d](/filings/0000764065-25-000124.md) | [0.0 d](/filings/0000764065-25-000149.md) | [0.0 d](/filings/0000764065-26-000025.md) | [0.0](/filings/0000764065-25-000103.md) | [0.0 d](/filings/0000764065-25-000124.md) | [0.0 d](/filings/0000764065-25-000149.md) | [0.0 d](/filings/0000764065-26-000025.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [515](/filings/0000764065-24-000108.md) | [514](/filings/0000764065-24-000167.md) | [509](/filings/0000764065-24-000206.md) | [492](/filings/0000764065-25-000103.md) | [474](/filings/0000764065-25-000124.md) | [468](/filings/0000764065-25-000149.md) | [495](/filings/0000764065-26-000070.md) | [495](/filings/0000764065-26-000100.md) | [495](/filings/0000764065-26-000115.md) | [570](/filings/0000764065-26-000070.md) | [571](/filings/0000764065-26-000100.md) | [574](/filings/0000764065-26-000115.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 570,584,966 at 2026-10-20, from the cover of the [10-Q filed 2026-10-20](/filings/0000764065-26-000115.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.